Minireviews
Copyright ©The Author(s) 2018.
World J Clin Oncol. Apr 10, 2018; 9(2): 26-32
Published online Apr 10, 2018. doi: 10.5306/wjco.v9.i2.26
Figure 1
Figure 1 Diagram summarizing the possibility to monitor breast cancer from the blood circulating DNA.
Figure 2
Figure 2 Summary of the literature data on cfDI determination in primary breast cancer vs healthy females. 1Note that cfDI by β-actin was evaluated as difference between large and short amplicons and not as ratio longer to shorter amplicons. BC: Breast cancer; MBC: Metastatic breast cancer.